Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001745672-18-000001
Filing Date
2018-07-09
Accepted
2018-07-06 20:02:13
Documents
1
Effectiveness Date
2018-07-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6539
  Complete submission text file 0001745672-18-000001.txt   7566
Mailing Address 17511 LOS MORROS RANCHO SANTA FE CA 92067
Business Address 17511 LOS MORROS RANCHO SANTA FE CA 92067 858-413-7899
Imbria Pharmaceuticals, Inc. (Filer) CIK: 0001745672 (see all company filings)

EIN.: 830858012 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-316241 | Film No.: 18943203